Supply is outstripping demand for life sciences, but AI and new biotech could help absorb some of the new space, according to Knight Frank.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results